Oral Mucositis Management in Pediatric Oncology Patients

NCT06711315 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2024-12-02

No results posted yet for this study

Summary

This study evaluated the impact of an oral mucositis care protocol on the severity of mucositis.

The main questions it aims to answer are:

-What is the severity of mucositis in parents and children who receive oral mucositis education?

The data were collected using a descriptive information form, the Children's International Mucositis Evaluation Scale (ChIMES), and the WHO Oral Mucositis Grading Scale. Standard care was applied to the control group. For the intervention group, an oral care protocol was prepared, and the patients received training. The oral care intervention was applied for 14 days and monitored by the researcher. The patients were monitored for oral mucositis on Days 0, 3, 7, and 14. Those in the intervention group received a calendar for documenting their oral care practices.

Conditions

  • Childhood Oncology
  • Mucositis Oral

Interventions

BEHAVIORAL

Oral Mucosit Care Protocol

The children in the intervention group were subjected to a four-stage intervention carried out by the nurse researcher. The practices in each stage were as follows. Stage 1: Oral care protocol training to prevent oral mucositis Stage 2: Introduction and application of training material (brochure) Stage 3: Introduction and implementation of oral care calendar Stage 4: Implementation of oral care protocol

Sponsors & Collaborators

  • Zubeyde Ezgi Ercelik

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
6 Weeks
Max Age
18 Weeks
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-06-01
Primary Completion
2024-08-06
Completion
2024-09-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06711315 on ClinicalTrials.gov